Strides Pharma hits 52-week high as CDMO arm secures ₹801 cr in pre-listing round

October 16, 2024
Uncategorized

Strides Pharma Science announced that its associate, OneSource Specialty Pharma, has raised ₹801 crore from domestic and foreign institutional investors in a pre-listing round.

Strides Pharma hits 52-week high as CDMO arm secures ₹801 cr in pre-listing round

Leave a ReplyCancel Reply

RITES secures $20.6 million international order for diesel electric locomotives

Cement, metals, banks: Dharmesh Kant’s playbook for the next 6–9 months

WeWork India Q3 Results: Stock recovers from initial drop as profit expands despite higher costs

Onesource Specialty Pharma shares tank 18% after semaglutide delay hurts Q3 performance

Wockhardt antibiotic Foviscu successfully met primary endpoint in phase 3 clinical trial